Vital Access


Money: Undisclosed
Sell Side Advisor

August 2018

Acquired by Advent Access

Company Overview

  • VWING is a commercially-pure titanium needle guide that is sutured onto the AV fistula by a vascular surgeon; the innovative guide makes hemodialysis access a safe, reliable, and easier experience for the patient


  • Given its success in lowering infection rates, vascular aneurysms, and associated costs, VWING is poised to become the “standard of care” for difficult-to-cannulate arteriovenous (AV) fistulas. VWING key benefits include the minimization of complications, and reduction of catheter days, which can ultimately decrease costs in the critically important hemodialysis market

Value Provided by Frontcourt

  • Engaged by Deerfield Asset Management to auction off Vital Access assets
  • Created Confidential Information Memorandum and summary overview deck
  • Completed a comprehensive competitive analysis
  • Conducted thorough due diligence including attending key industry conferences and events to formulate the strategy
  • Identified and coordinated with industry KOLs to support and endorse our process and approach
  • Conducted auction and interacted with dozens of potential buyers
  • Negotiated terms with potential bidders
  • Presented the seller with options and recommendation
  • Facilitated confirmatory buyer due diligence
  • Completed Sale transaction to Asia-based MedTech Company

We want to work with you

We can't wait to meet you. Hear your story. Connect.

Contact Us